Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
post your news I subscribe newsletter I contact us
29.02.2008 Solvay Pharmaceuticals S.A. acknowledges decision of Wyeth Pharmaceuticals to terminate the collaboration agreement on bifeprunox
29.02.2008 Anti-Cancer Agent Herceptin® Obtained Approval for a New Indication for Adjuvant Therapy in Breast Cancer that Overexpresses HER2
29.02.2008 Combination Therapy of Anti-Cancer Agents, Xeloda®, Elplat® and Avastin®, and Monotherapy of Xeloda® filed for Advanced or Recurrent Colorectal Cancer
28.02.2008 MorphoSys AG Reports Financial Results for Fiscal Year 2007 - Significant Increase of Revenues, Operating Profit and Net Income
28.02.2008 Dyax Corp. Announces First Market Approval from Licensing and Funded Research Program
27.02.2008 MorphoSys and Sigma-Aldrich Enter into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
25.02.2008 Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
25.02.2008 Board of Life Therapeutics enters into Terms of Agreement with Octapharma re Management Services, Loan, and Put & Call Option
21.02.2008 MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies
21.02.2008 Antisoma plc reports half-year results
19.02.2008 Pharmion Corporation Announces 2007 Operating Results
18.02.2008 Axis-Shield receives United States FDA 510(K) Clearance for Afinion Albumin/Creatinine Ratio Test
18.02.2008 Lundbeck further strengthens pipeline by moving Lu AA34893 into clinical phase II
18.02.2008 Merck Triples 2007 Profit After Tax to EUR 3.5 Billion
14.02.2008 Active Biotech Year-End Report January-December 2007
13.02.2008 LFE Appoints New Director and Chairman of Board
14.02.2008 Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
13.02.2008 Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
12.02.2008 ACADIA Pharmaceuticals Appoints John J. Kaiser as Vice President, Strategic Marketing and Commercial Development
